Search results for "THYROID"

showing 10 items of 803 documents

Sinusitis in Thyroid Associated Ophthalmopathy

1993

In 19 patients with thyroid associated ophthalmopathy undergoing orbital decompression, histologic examination of paranasal sinus mucosa revealed moderate to severe inflammatory alterations in all patients. Only 2/19 patients had a history of chronic sinusitis. In 4/19 patients, mucosal abnormalities of the paranasal sinuses were found on preoperative computed tomography CT scans. Postoperatively, 10/19 patients developed purulent sinusitis. It is suggested that patients suffering from thyroid associated ophthalmopathy have an increased incidence of histologically detectable inflammatory changes of paranasal sinus mucosa. Because of preexisting mucosal inflammation, these patients are pron…

Paranasal sinus mucosaModerate to severemedicine.medical_specialtybusiness.industryOrbital decompressionmedicine.diseaseGastroenterology03 medical and health sciences0302 clinical medicineOtorhinolaryngology030220 oncology & carcinogenesisInternal medicineotorhinolaryngologic diseasesmedicine030223 otorhinolaryngologySinusitisbusinessThyroid-Associated OphthalmopathyAmerican Journal of Rhinology
researchProduct

[Informed consent in thyroid and parathyroid surgery].

2005

The Authors outline the law problems and the practice implications of thyroid and parathyroid surgery from the point of view of the informed consensus of the patient, and expose the criteria they usually adopt in their clinical practice for such procedures. This problem is particularly important because is exceptionally needed in emergency; therefore the preoperative information must be completed as possible, illustrating the risks of the procedure and the possible solutions alternative to surgery.

Parathyroid GlandsInformed ConsentThyroid GlandHumansInformed consent parathyroid glands thyroid surgeryAnnali italiani di chirurgia
researchProduct

Parathyroid hormone-related protein (PTHrP)-dependent modulation of gene expression signatures in cancer cells

2022

PTHrP is encoded by PTHLH gene which can generate by alternative promoter usage and splicing mechanisms at least three mature peptides of 139, 141 and 173 amino acids with distinct carboxy terminus. PTHrP may undergo proteolytic processing into smaller bioactive forms, comprising an amino terminus peptide, which is the mediator of the "classical" PTH-like effect, as well as midregion and carboxy terminus peptides that act as multifaceted critical regulator of proliferation, differentiation and apoptosis via the reprogramming of gene expression in normal and neoplastic cells. Moreover, a nuclear/nucleolar localization signal sequence is present in the [87-107] domain allowing PTHrP nuclear i…

Parathyroid HormoneNeoplasmsParathyroid Hormone-Related ProteinHumansApoptosisSettore BIO/06 - Anatomia Comparata E CitologiaPeptidesTranscriptomeGene signatures Bone tumor Breast tumor Gastrointestinal tumor Prostate tumor Lung cancer Leukemia/lymphoma
researchProduct

The neuropeptide Pth2 modulates social behavior and anxiety in zebrafish

2021

SummaryAnimal behavior is strongly context-dependent and behavioral performance is often modulated by internal state. In particular, different social contexts can alter anxiety levels and modulate social behavior. The vertebrate-specific neuropeptide parathyroid hormone 2 (pth2) is directly regulated by the presence or absence of conspecifics in zebrafish. As its cognate receptor, the parathyroid hormone 2 receptor (pth2r), is widely expressed across the brain, we tested fish lacking the functional Pth2 peptide in several anxiety-related and social paradigms. Rodents lacking PTH2 display increased anxiety-related behavior. Here we show that the propensity to react to sudden stimuli with an …

Parathyroid hormone 2 receptorEarly juvenilemedicineNeuropeptideAnxietyEscape responseBiologymedicine.symptomReceptorbiology.organism_classificationZebrafishNeuroscienceSocial preferences
researchProduct

Comparison between Rapid Intraoperative and Central Laboratory Parathormone Dosage in 12 Kidney Transplant Candidates

2016

Abstract Background The rapid intraoperative parathormone (PTH) and at central laboratory PTH dosage gives similar results. The central laboratory provides results in longer times and higher costs. Intraoperative measurement can reduce time and costs during parathyroidectomy. Methods Twelve patients undergoing parathyroidectomy for hyperparathyroidism renal transplant candidates were included. Diagnosis was made by laboratory tests (serum calcium, PTH) and imaging techniques (ultrasonography and scintigraphy). All patients presented PTH levels of >400 pg/mL (the limit value to be maintained in list for kidney transplantation) and resistant to medical therapy. For each patient, 2 blood sampl…

ParathyroidectomyAdultMalemedicine.medical_specialtyWaiting Listsmedicine.medical_treatmentOperative TimeParathyroid hormoneScintigraphyKidney transplantCentral laboratory03 medical and health sciences0302 clinical medicineMonitoring IntraoperativemedicineHumansKidney transplantationParathyroidectomyHyperparathyroidismTransplantationmedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseKidney TransplantationSurgery; TransplantationSurgerySettore MED/18 - Chirurgia GeneraleParathyroid Hormone030220 oncology & carcinogenesisAnesthesiaKidney Failure Chronic030211 gastroenterology & hepatologySecondary hyperparathyroidismFemaleHyperparathyroidism SecondarySurgerybusiness
researchProduct

Use of monitoring intraoperative parathyroid hormone during parathyroidectomy in patients on waiting list for renal transplantation.

2007

This report describes the use of intraoperative parathyroid hormone (ioPTH) assay during parathyroidectomy for patients with secondary hyperparathyroidism on the waiting list for renal transplantation. The levels of ioPTH were determined among waiting list patients undergoing subtotal parathyroidectomy and tertiary hyperparathyroidism patients undergoing procedures. The levels of ioPTH were significantly reduced at 10 minutes by 59.7,3% among with secondary hyperparathyroidism and 68.9% among tertiary hyperparathyroidism. A 15 minutes it was 85% in secondary hyperparathyroidism and 89.7% in tertiary hyperparathyroidism. A decrement of 50% in basal values at 10 minutes and 85% decrement or m…

ParathyroidectomyAdultMalemedicine.medical_specialtyendocrine system diseasesWaiting Listsmedicine.medical_treatmentParathyroid hormoneTertiary hyperparathyroidismSubtotal ParathyroidectomyMonitoring IntraoperativemedicineHumansKidney transplantationAgedParathyroidectomyTransplantationbusiness.industryMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationSettore MED/18 - Chirurgia Generalemedicine.anatomical_structureParathyroid HormoneSurgerySecondary hyperparathyroidismParathyroid glandFemaleHyperparathyroidism SecondarybusinessParathyroidectomy hyperparathyroidismTransplantation proceedings
researchProduct

A complex case of fatal calciphylaxis in a female patient with hyperparathyroidism secondary to end stage renal disease of graft and coexistence of h…

2012

Background: Calciphylaxis is a potentially fatal complication of persistent secondary hyperparathyroidism; its cause is still not clear. Unfortunately there is no close relation in severity of clinical picture, serological and pathological alteration. For this reason the prognosis is difficult to establish. Administration of sodium thiosulphate may reduce the precipitation of calcium crystals and improve the general clinical conditions before surgical parathyroidectomy, which seems the only therapeutic approach able to reduce the mortality risk in these patients. Methods and Results: A 60 year old female patient suffering from End Renal Stage Disease, on haemodialysis from 2001 due to the o…

ParathyroidectomyGraft Rejectionmedicine.medical_specialtymedicine.medical_treatmentCalciphylaxiSettore MED/08 - Anatomia PatologicaGeneral Biochemistry Genetics and Molecular BiologyEnd stage renal diseaseFatal OutcomeSecondary hyperparathyroidism; Calciphylaxis; Kidney transplant; ParathyroidectomymedicineHumansKidney transplantDialysisParathyroidectomySettore MED/14 - NefrologiaCalciphylaxisHyperparathyroidismbusiness.industryCalciphylaxisMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationSecondary hyperparathyroidismSettore MED/18 - Chirurgia GeneraleHemolytic-Uremic SyndromeKidney Failure ChronicSecondary hyperparathyroidismFemaleHyperparathyroidism SecondaryComplicationbusinessBiomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
researchProduct

Mapping the centers performing endocrine neck surgery in Italy

2020

Background. Quality of care and provider’s experience seem to be strictly connected in any field of surgery. Aim of this study is to identify a method to classify the centers on the basis of the number of thyroidectomies and parathyroidectomies performed. Methods. We listed 666 centers performing endocrine neck surgery in 2015, from the database of the Italian Health Ministry. We performed a descriptive statistic analysis with a dedicated software. We identified the outliers, according to a previous literature review, in those centers performing >1000 and < 10 thyroidectomies, >100 and < 3 parathyroidectomies and we excluded them to our analysis. The remaining centers were group…

ParathyroidectomyHigh volume centerItalyThyroidectomyHumansHigh volume surgeonHospitalsEndocrine neck surgery
researchProduct

Tertiary hyperparathyroidism: a review

2021

Abstract: Tertiary hyperparathyroidism (HPT III) occurs when an excess of parathyroid hormone (PTH) is secreted by parathyroid glands, usually after longstanding secondary hyperparathyroidism. Some authorities reserve the term for secondary hyperparathyroidism that persists after successful renal transplantation. Long-standing chronic kidney disease (CKD) is associated with several metabolic disturbances that lead to increased secretion of PTH, including hyperphosphatemia, calcit-riol deficiency, and hypocalcaemia. Hyperphosphatemia has a direct stimulatory effect on the parathyroid gland cell resulting in nodular hyperplasia and increased PTH secretion. Prolonged hypocalcaemia also causes …

ParathyroidectomyHyperplasiametabolic disturbancesparathyroidec-tomyHypocalcemiaCalcimimeticstertiary hyperparathyroidismKidney TransplantationTransplantation AutologousHyperphosphatemiaParathyroid GlandsParathyroid HormoneHumansHyperparathyroidism SecondaryRenal Insufficiency Chronic
researchProduct

Efficacy and safety of preoperative with Lugol's iodine solution euthyroid patients with Graves' disease (LIGRADIS Trial): study protocol for a multi…

2021

"Artículo escrito por un elevado número de autores, solo se referencian el que aparece en primer lugar, el nombre del grupo de colaboración, si le hubiere, y los autores pertenecientes a la UAM"

ParathyroidectomyMedicine (General)medicine.medical_specialtyMedicinaGraves' diseasemedicine.medical_treatmentLugol's iodineHyperthyroidismArticlelaw.invention03 medical and health scienceschemistry.chemical_compoundR5-9200302 clinical medicineRandomized controlled triallawmedicineEuthyroid030212 general & internal medicineThyroid cancerPharmacologyLugol's solutionCirurgiabusiness.industryIodeThyroidectomyGeneral Medicinemedicine.diseaseGraves' diseaseThyroid surgerySurgeryThyroid diseasesMalalties de la tiroideHypoparathyroidismchemistrySurgerybusiness030217 neurology & neurosurgeryIodine
researchProduct